-
821
Effects of perfluorolauric acid exposure on intestinal microbial community and physiological health indicators in mice
Published 2025-01-01Subjects: Get full text
Article -
822
The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease
Published 2025-01-01Subjects: Get full text
Article -
823
-
824
Early disease detection expert system development: primary machining software applications and dependences
Published 2018-09-01Subjects: Get full text
Article -
825
Serum Lactate Dehydrogenase Is a Novel Predictor for the Severity in the Patients With MAFLD: A Cross-Sectional Study in Hefei, China
Published 2025-02-01Subjects: “…metabolic associated fatty liver disease (mafld)…”
Get full text
Article -
826
Limosilactobacillus mucosae FZJTZ26M3 prevents NAFLD in mice through modulation of lipid metabolism and gut microbiota dysbiosis
Published 2024-05-01Subjects: Get full text
Article -
827
Global burden of five major types of gastrointestinal cancer
Published 2024-07-01Subjects: Get full text
Article -
828
Estradiol-dependent and independent effects of FGF21 in obese female mice
Published 2022-04-01Subjects: Get full text
Article -
829
-
830
-
831
Regulatory role of S1P and its receptors in sepsis-induced liver injury
Published 2025-01-01Subjects: Get full text
Article -
832
-
833
Study on the status of liver function abnormalities and its related factors in patients with severe mental disorders in Shanghai community
Published 2024-11-01Subjects: Get full text
Article -
834
-
835
-
836
Repetitive Transcranial Magnetic Stimulation for Treatment of Post-stroke Depression of Liver-Qi Stagnation Type in 33 Cases
Published 2016-12-01Subjects: Get full text
Article -
837
Editorial: Gene therapy and genome editing for metabolic liver disorders
Published 2025-01-01Subjects: Get full text
Article -
838
Proportional mortality and years of potential life lost due to liver diseases among agricultural workers, Brazil, 2017 to 2022
Published 2025-01-01Subjects: “…Liver Diseases…”
Get full text
Article -
839
-
840
An Effect of Ursodeoxycholic Acid on Inflammation, Steatosis and Liver Fibrosis and Atherogenesis Factors in Patients with Non-Alcoholic Fatty Liver Disease: Results of the USPEH S...
Published 2020-01-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article